APOE and COVID-19: It has been shown in older, Spanish population that ε4 variant of the APOE gene is associated with the presence and clinical severity of coronavirus infection.[24] In the UK biobank cohort, the ε4 variant was associated with increased risk of test positivity and of mortality with test‐confirmed COVID‐19.[25]